CureVac – THE OVAL CIRCLE

EU

Germany’s CureVac jab shows only 48% effectiveness against Covid-19 in final stage of trial, driving stock plunge

Posted on July 3, 2021July 3, 2021By Editor

German biotech firm CureVac said its coronavirus vaccine showed just 48% efficacy against Covid-19 following its final analysis, marking only a slight improvement on the company’s last trial while sending its stock value tumbling. … Read More >Germany’s CureVac jab shows only 48% effectiveness against Covid-19 in final stage of trial, driving stock plunge

EU

EU drugs regulator says it won’t impose 50% efficacy threshold for Covid-19 vaccines after disappointing result in CureVac trial

Posted on June 20, 2021June 20, 2021By Editor

The European Medicines Agency (EMA) has said it will not bring in a minimum efficacy threshold for Covid-19 vaccines. The comment comes after clinical trials showed Germany’s CureVac jab to be only 47% effective against the virus. … Read More >EU drugs regulator says it won’t impose 50% efficacy threshold for Covid-19 vaccines after disappointing result in CureVac trial